La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

CM Hospitalar S/A Croissance future

Future contrôle des critères 3/6

CM Hospitalar S/A devrait augmenter ses bénéfices et son chiffre d'affaires de 18% et de 7.5% par an respectivement. Le BPA devrait croître de de 23.6% par an. Le rendement des capitaux propres devrait être 7.1% dans 3 ans.

Informations clés

23.1%

Taux de croissance des bénéfices

22.8%

Taux de croissance du BPA

Healthcare croissance des bénéfices	29.0%
Taux de croissance des recettes	6.9%
Rendement futur des capitaux propres	6.7%
Couverture par les analystes	Good
Dernière mise à jour	29 Aug 2024

Mises à jour récentes de la croissance future

Recent updates

Capital Allocation Trends At CM Hospitalar S/A (BVMF:VVEO3) Aren't Ideal

Jul 30

CM Hospitalar S/A (BVMF:VVEO3) Looks Inexpensive After Falling 32% But Perhaps Not Attractive Enough

Jun 25

CM Hospitalar S/A (BVMF:VVEO3) Not Doing Enough For Some Investors As Its Shares Slump 49%

May 11

CM Hospitalar S/A (BVMF:VVEO3) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Apr 01

Analysts Are Updating Their CM Hospitalar S/A (BVMF:VVEO3) Estimates After Its Annual Results

Mar 29

Why Investors Shouldn't Be Surprised By CM Hospitalar S/A's (BVMF:VVEO3) 28% Share Price Plunge

Mar 27

Here's Why CM Hospitalar S/A (BVMF:VVEO3) Has A Meaningful Debt Burden

Jan 15

Here's What To Make Of CM Hospitalar S/A's (BVMF:VVEO3) Decelerating Rates Of Return

Dec 14

CM Hospitalar S/A (BVMF:VVEO3) Has More To Do To Multiply In Value Going Forward

Jun 07

Returns On Capital Signal Tricky Times Ahead For CM Hospitalar S/A (BVMF:VVEO3)

Jan 16

Be Wary Of CM Hospitalar S/A (BVMF:VVEO3) And Its Returns On Capital

Aug 31

Statutory Earnings May Not Be The Best Way To Understand CM Hospitalar S/A's (BVMF:VVEO3) True Position

May 17

Pinning Down CM Hospitalar S/A's (BVMF:VVEO3) P/E Is Difficult Right Now

Dec 09

Prévisions de croissance des bénéfices et des revenus

BOVESPA:VVEO3 - Estimations futures des analystes et données financières antérieures (BRL Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
12/31/2026	13,798	206	306	349	6
12/31/2025	12,871	206	405	297	8
12/31/2024	11,749	-48	845	158	5
6/30/2024	11,462	183	-544	-273	N/A
3/31/2024	11,242	326	-662	-372	N/A
12/31/2023	11,084	360	-1,198	-896	N/A
9/30/2023	10,805	162	-142	170	N/A
6/30/2023	10,234	209	-122	173	N/A
3/31/2023	9,647	200	-222	52	N/A
12/31/2022	8,747	260	273	533	N/A
9/30/2022	7,741	278	140	329	N/A
6/30/2022	6,963	286	-17	136	N/A
3/31/2022	6,634	458	79	213	N/A
12/31/2021	6,219	395	194	320	N/A
9/30/2021	6,031	372	102	189	N/A
6/30/2021	5,746	337	N/A	N/A	N/A
3/31/2021	5,055	136	88	158	N/A
12/31/2020	4,413	122	132	186	N/A
12/31/2019	3,003	36	137	163	N/A
12/31/2018	2,641	34	58	86	N/A
12/31/2017	1,696	59	N/A	54	N/A
12/31/2016	1,148	165	N/A	59	N/A
12/31/2015	998	-1	N/A	-27	N/A
12/31/2014	866	3	N/A	-82	N/A
12/31/2013	720	3	N/A	16	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de VVEO3 ( 18% par an) est supérieure au taux d'épargne ( 10.1% ).

Bénéfices vs marché: Les bénéfices de VVEO3 ( 18% par an) devraient croître plus rapidement que le marché BR ( 14.9% par an).

Croissance élevée des bénéfices: Les bénéfices de VVEO3 devraient augmenter de manière significative au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de VVEO3 ( 7.5% par an) devrait croître plus lentement que le marché de BR ( 7.7% par an).

Croissance élevée des revenus: Le chiffre d'affaires de VVEO3 ( 7.5% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de VVEO3 devrait être faible dans 3 ans ( 7.1 %).

CM Hospitalar S/A Croissance future

Future contrôle des critères 3/6

Informations clés

Mises à jour récentes de la croissance future

Consensus EPS estimates fall by 418%

Price target decreased by 12% to R$8.77

Consensus EPS estimates fall from profit to R$0.0073 loss

Price target decreased by 28% to R$11.01

Price target decreased by 7.1% to R$15.33

Consensus EPS estimates fall by 11%

Recent updates

Consensus EPS estimates fall by 418%

Price target decreased by 12% to R$8.77

Investor sentiment deteriorates as stock falls 23%

Second quarter 2024 earnings: EPS misses analyst expectations

Now 21% undervalued after recent price drop

Capital Allocation Trends At CM Hospitalar S/A (BVMF:VVEO3) Aren't Ideal

Now 21% undervalued after recent price drop

Investor sentiment improves as stock rises 19%

CM Hospitalar S/A (BVMF:VVEO3) Looks Inexpensive After Falling 32% But Perhaps Not Attractive Enough

Consensus EPS estimates fall from profit to R$0.0073 loss

Investor sentiment deteriorates as stock falls 17%

Investor sentiment deteriorates as stock falls 25%

Price target decreased by 28% to R$11.01

Now 28% undervalued after recent price drop

New major risk - Revenue and earnings growth

CM Hospitalar S/A (BVMF:VVEO3) Not Doing Enough For Some Investors As Its Shares Slump 49%

First quarter 2024 earnings released: EPS: R$0.01 (vs R$0.13 in 1Q 2023)

Price target decreased by 7.1% to R$15.33

Consensus EPS estimates fall by 11%

CM Hospitalar S/A (BVMF:VVEO3) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Analysts Are Updating Their CM Hospitalar S/A (BVMF:VVEO3) Estimates After Its Annual Results

New major risk - Share price stability

Why Investors Shouldn't Be Surprised By CM Hospitalar S/A's (BVMF:VVEO3) 28% Share Price Plunge

Full year 2023 earnings released: EPS: R$1.20 (vs R$0.92 in FY 2022)

Consensus EPS estimates fall by 10%

Price target decreased by 9.5% to R$22.11

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 17%

Price target decreased by 8.4% to R$23.89

Here's Why CM Hospitalar S/A (BVMF:VVEO3) Has A Meaningful Debt Burden

Here's What To Make Of CM Hospitalar S/A's (BVMF:VVEO3) Decelerating Rates Of Return

Price target decreased by 7.7% to R$25.61

New minor risk - Shareholder dilution

Third quarter 2023 earnings released: EPS: R$0.021 (vs R$0.19 in 3Q 2022)

Consensus EPS estimates fall by 10%

Second quarter 2023 earnings: Revenues miss analyst expectations

Price target increased by 7.0% to R$26.26

Consensus EPS estimates fall by 14%

CM Hospitalar S/A (BVMF:VVEO3) Has More To Do To Multiply In Value Going Forward

First quarter 2023 earnings released: EPS: R$0.13 (vs R$0.34 in 1Q 2022)

Consensus EPS estimates fall by 13%

Full year 2022 earnings released

Returns On Capital Signal Tricky Times Ahead For CM Hospitalar S/A (BVMF:VVEO3)

Now 20% undervalued after recent price drop

Now 21% undervalued after recent price drop

Third quarter 2022 earnings released

Third quarter 2022 earnings released

Investor sentiment deteriorated over the past week

Be Wary Of CM Hospitalar S/A (BVMF:VVEO3) And Its Returns On Capital

CM Hospitalar S/A (BOVESPA:VVEO3) agreed to acquire Neve Industria e Comercio de Produtos Cirurgicos and Nutrifica Comercio de Nutricao Enteral e Parenteral for BRL 110 million.

Second quarter 2022 earnings: EPS misses analyst expectations

Statutory Earnings May Not Be The Best Way To Understand CM Hospitalar S/A's (BVMF:VVEO3) True Position

First quarter 2022 earnings: Revenues exceed analyst expectations

Upcoming dividend of R$0.16 per share

Full year 2021 earnings: Revenues exceed analyst expectations

Consensus forecasts updated

Investor sentiment improved over the past week

Pinning Down CM Hospitalar S/A's (BVMF:VVEO3) P/E Is Difficult Right Now

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Prévisions de croissance des bénéfices et des revenus

Prévisions de croissance des analystes

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

Découvrir les entreprises en croissance